Evolving Goals in Multiple Myeloma Treatment
Experts explore the evolving goals in treating newly diagnosed multiple myeloma patients, including balancing effective therapies, achieving MRD negative remission, and managing toxicities.
Stay updated with breaking news from Deep Remission. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts explore the evolving goals in treating newly diagnosed multiple myeloma patients, including balancing effective therapies, achieving MRD negative remission, and managing toxicities.
Health care professionals delve into discussions on using quadruplets in multiple myeloma treatment, addressing challenges and considerations for high-risk patients.
Experts discuss challenges in induction regimens for transplant ineligible myeloma patients, and evolving approaches, quad regimens, dynamic frailty, and upcoming trials shaping future treatment options.
France: Achieving prolonged clinical remission off steroids with full endoscopic remission in patients with early Crohn's disease (CD) was not related to decreased disease progression, according to a...